Methyl Donors Reduce Cell Proliferation by Diminishing Erk-Signaling and NFkB Levels, While Increasing E-Cadherin Expression in Panc-1 Cell Line.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
25 Feb 2022
Historique:
received: 08 01 2022
revised: 22 02 2022
accepted: 24 02 2022
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 9 4 2022
Statut: epublish

Résumé

Pancreatic cancer is an aggressive malignancy with high metastatic potential. There are several lifestyle-related determinants in its etiology, including diet. Methyl donors are dietary micronutrients which play an important role in fueling vital metabolic pathways, and as bioactive food components provide methyl groups as substrates and cofactors. The imbalanced nutritional status of methyl donors has recently been linked to pathological conditions. Therefore, we hypothesized that dietary methyl donors may improve the physiology of cancer patients, including those with pancreatic cancer, and could be used for intervention therapy. In this study, methyl-donor treatment (L-methionine, choline chloride, folic acid and vitamin B12) of an aggressive pancreatic adenocarcinoma cell line (Panc-1) resulted in significantly increased p21

Identifiants

pubmed: 35269689
pii: ijms23052546
doi: 10.3390/ijms23052546
pmc: PMC8910410
pii:
doi:

Substances chimiques

Cadherins 0
Cyclin-Dependent Kinase Inhibitor p21 0
NF-kappa B 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Ministry of Hungary for Innovation and Technology
ID : NVKP_16-1-2016-0042
Organisme : National Research, Development and Innovation Office of Hungary
ID : ÚNKP-21-4-I-SE-19

Références

J Nutr. 2002 Aug;132(8 Suppl):2336S-2339S
pubmed: 12163688
Genes Dev. 2007 Jun 1;21(11):1396-408
pubmed: 17510282
Oncotarget. 2016 Apr 12;7(15):19863-83
pubmed: 26959884
Front Oncol. 2018 Oct 31;8:493
pubmed: 30430082
Invest New Drugs. 2019 Aug;37(4):738-747
pubmed: 30993587
Cancer Lett. 2012 Sep 28;322(2):169-76
pubmed: 22450749
Cancer Gene Ther. 2022 Feb;29(2):167-177
pubmed: 33514882
Cell Res. 2000 Dec;10(4):267-78
pubmed: 11191349
Lab Invest. 2016 Dec;96(12):1268-1278
pubmed: 27775688
Nutrients. 2020 Jan 16;12(1):
pubmed: 31963141
Acta Oncol. 2016 Sep - Oct;55(9-10):1158-1160
pubmed: 27551890
Cell Metab. 2017 Jan 10;25(1):27-42
pubmed: 27641100
Nutr J. 2020 Oct 4;19(1):111
pubmed: 33012287
Leukemia. 2002 Feb;16(2):289-93
pubmed: 11840297
Cancer Lett. 2018 May 1;421:127-134
pubmed: 29432846
Public Health Nutr. 2016 Jun;19(8):1446-56
pubmed: 26373257
World J Oncol. 2019 Feb;10(1):10-27
pubmed: 30834048
Br J Cancer. 2013 Oct 1;109(7):1926-44
pubmed: 23907430
J Med Chem. 2021 Sep 9;64(17):12938-12963
pubmed: 34424711
Ann Oncol. 2014 Aug;25(8):1609-15
pubmed: 24827130
Clin Cancer Res. 2000 Sep;6(9):3530-5
pubmed: 10999740
Int J Oncol. 2006 Jul;29(1):185-92
pubmed: 16773199
Clin Breast Cancer. 2020 Aug;20(4):e469-e480
pubmed: 32241696
Proc Natl Acad Sci U S A. 2021 Feb 9;118(6):
pubmed: 33526692
J Immunol. 2010 Mar 1;184(5):2289-96
pubmed: 20139273
Nat Rev Dis Primers. 2016 Apr 21;2:16022
pubmed: 27158978
Eur J Nutr. 2019 Jun;58(4):1591-1602
pubmed: 29744609
Nat Chem Biol. 2013 May;9(5):300-6
pubmed: 23455543
Cancer Lett. 2014 Apr 10;345(2):203-9
pubmed: 23981573
Gastroenterology. 2020 Jul;159(1):335-349.e15
pubmed: 32247694
Oncogene. 2004 Apr 22;23(19):3284-95
pubmed: 14981547
Int J Cancer. 2007 Jun 1;120(11):2344-52
pubmed: 17311258
Front Public Health. 2020 Dec 15;8:550753
pubmed: 33384976
IUBMB Life. 2020 Jul;72(7):1415-1425
pubmed: 32150326
Nature. 2006 May 25;441(7092):431-6
pubmed: 16724054
Cancer Cell. 2009 Apr 7;15(4):283-93
pubmed: 19345327
Sci Rep. 2021 Jun 16;11(1):12668
pubmed: 34135415
Br J Cancer. 2014 Apr 29;110(9):2327-38
pubmed: 24667649
Urol Res. 1993;21(5):359-62
pubmed: 7506464
In Vitro Cell Dev Biol Anim. 2008 Jul-Aug;44(7):268-72
pubmed: 18498022
J Endocrinol Invest. 2008 Sep;31(9):809-19
pubmed: 18997494
Dig Dis Sci. 2021 Jul;66(7):2368-2379
pubmed: 32770489
Annu Rev Anim Biosci. 2019 Feb 15;7:263-287
pubmed: 30412672
Int J Mol Sci. 2021 Mar 30;22(7):
pubmed: 33808426
J Nutr. 2002 Aug;132(8 Suppl):2333S-2335S
pubmed: 12163687
Blood Cancer J. 2017 Sep 8;7(9):e603
pubmed: 28885612
J Nutr Biochem. 2012 Aug;23(8):853-9
pubmed: 22749138
Pigment Cell Melanoma Res. 2021 Nov;34(6):1039-1048
pubmed: 34018676
Pancreas. 2014 May;43(4):619-23
pubmed: 24658320
Nat Rev Cancer. 2009 Jun;9(6):400-14
pubmed: 19440234
Nutrients. 2019 Mar 13;11(3):
pubmed: 30871166
Mol Cancer. 2013 Aug 02;12:86
pubmed: 23915189

Auteurs

Eva Kiss (E)

1st Department of Internal Medicine and Oncology, Oncology Profile, Semmelweis University, 1083 Budapest, Hungary.

Gertrud Forika (G)

1st Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.

Magdolna Dank (M)

1st Department of Internal Medicine and Oncology, Oncology Profile, Semmelweis University, 1083 Budapest, Hungary.

Tibor Krenacs (T)

1st Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.

Zsuzsanna Nemeth (Z)

1st Department of Internal Medicine and Oncology, Semmelweis University, 1083 Budapest, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH